SCHEMBL1097950

SCHEMBL1097950

O=S(=O)(O)c1c(N=Nc2cccc3ccccc23)c(O)c2ccccc2c1S(=O)(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 5/20 0.58
▸ HIF1A Q16665 3/20 0.58
▸ ALDH1A1 P00352 2/20 0.58
▸ CYP2C9 P11712 2/20 0.54
▸ TSHR P16473 1/20 0.54
▸ PTPRA P18433 1/20 0.54
▸ PTPRB P23467 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ RAPGEF4 Q8WZA2 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ MAPK1 P28482 3/20 0.53
▸ DNASE1L3 Q13609 1/20 0.53
▸ PTPN11 Q06124 1/20 0.52
▸ HPGD P15428 1/20 0.50
▸ CTRB1 P17538 1/20 0.49
▸ PRMT1 Q99873 1/20 0.47
▸ MPL P40238 5/20 0.47
▸ CTRC Q99895 2/20 0.47
▸ SENP2 Q9HC62 1/20 0.47
▸ SENP1 Q9P0U3 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8675476 0.92 CYP1A2 (0.55) CYP1A2HIF1AALDH1A1CYP2C9TSHR
SCHEMBL1098620 0.92 CYP1A2 (0.58) CYP1A2HIF1AALDH1A1CYP2C9TSHR
SCHEMBL2015717 0.89 CYP1A2 (0.55) CYP1A2HIF1AALDH1A1CYP2C9TSHR
SCHEMBL1759533 0.86 CYP1A2 (0.55) CYP1A2HIF1AALDH1A1CYP2C9TSHR
SCHEMBL9285885 0.83 CYP1A2 (0.52) CYP1A2HIF1AALDH1A1CYP2C9TSHR
SCHEMBL16689771 0.81 CYP1A2 (0.84) CYP1A2HIF1AALDH1A1CYP2C9TSHR
SCHEMBL14400947 0.81 CYP1A2 (0.72) CYP1A2HIF1AALDH1A1CYP2C9TSHR
SCHEMBL29894000 0.81 CYP1A2 (0.72) CYP1A2HIF1AALDH1A1CYP2C9TSHR
SCHEMBL1095777 0.80 POLB (0.53) CYP1A2ALDH1A1MAPK1HPGDPRMT1
SCHEMBL1866548 0.78 CYP1A2 (0.54) CYP1A2HIF1AALDH1A1CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3434764-B1 FABRIC AND HOME CARE PRODUCTS PROCTER & GAMBLE (US) 2026-04-08 — — EP disclosed
US-12338416-B2 Fabric and home care products with cold water protease THE PROCTER & GAMBLE COMPANY (US) 2025-06-24 — — US disclosed
EP-4159833-A2 FABRIC AND HOME CARE PRODUCTS The Procter & Gamble Company (US) 2023-04-05 — — EP disclosed
US-20210071113-A1 FABRIC AND HOME CARE PRODUCTS PROCTER & GAMBLE (US) 2021-03-11 — — US disclosed
US-10900000-B2 Fabric and home care products comprising cold water proteases THE PROCTER & GAMBLE COMPANY (US) 2021-01-26 — — US disclosed
EP-3434764-A2 FABRIC AND HOME CARE PRODUCTS The Procter & Gamble Company (US) 2019-01-30 — — EP disclosed
EP-3255135-B1 HIGH-EFFICIENCY PERFUME CAPSULES PROCTER & GAMBLE (US) 2019-01-02 — — EP disclosed
EP-2166078-B1 Laundry particle made by extrusion comprising a hueing dye PROCTER & GAMBLE (US) 2018-11-21 — — EP disclosed
US-20180171268-A1 FABRIC AND HOME CARE PRODUCTS PROCTER & GAMBLE (US) 2018-06-21 — — US disclosed
EP-2496681-B1 HIGH EFFICIENCY CAPSULES COMPRISING BENEFIT AGENT PROCTER & GAMBLE (US) 2017-09-06 — — EP disclosed
WO-2011060109-A1 CLEANING METHOD THE PROCTER & GAMBLE COMPANY (US) 2011-05-19 — — WO disclosed
US-20110107527-A1 CLEANING METHOD THE PROCTER & GAMBLE COMPANY 2011-05-12 — — US disclosed
US-20110111999-A1 HIGH-EFFICIENCY PERFUME CAPSULES THE PROCTER & GAMBLE COMPANY 2011-05-12 — — US disclosed
WO-2011056934-A1 HIGH EFFICIENCY CAPSULES COMPRISING BENEFIT AGENT THE PROCTER & GAMBLE COMPANY (US) 2011-05-12 — — WO disclosed
EP-2166078-A1 Laundry particle made by extrusion comprising a hueing dye The Procter & Gamble Company (US) 2010-03-24 — — EP disclosed
EP-2166077-A1 Particles comprising a hueing dye The Procter and Gamble Company (US) 2010-03-24 — — EP disclosed
US-20100069282-A1 Particles Comprising a Hueing Dye THE PROCTER & GAMBLE COMPANY 2010-03-18 — — US disclosed
US-20100069284-A1 Laundry Composition THE PROCTER & GAMBLE COMPANY 2010-03-18 — — US disclosed
US-20100069283-A1 LAUNDRY COMPOSITION THE PROCTER & GAMBLE COMPANY 2010-03-18 — — US disclosed
EP-2163608-A1 Laundry particle made by extrusion comprising a hueing dye and fatty acid soap The Procter & Gamble Company (US) 2010-03-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110107527-A1 CLEANING METHOD CAT, MPO, LBR CYP1A2 975/4885HIF1A 2665/4885ALDH1A1 1323/4885
US-20110111999-A1 HIGH-EFFICIENCY PERFUME CAPSULES PLIN5, PORCN, PIGS CYP1A2 629/4885HIF1A 2868/4885ALDH1A1 3767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback